135 related articles for article (PubMed ID: 26577856)
1. Equating salivary lactate dehydrogenase (LDH) with LDH-5 expression in patients with oral squamous cell carcinoma: An insight into metabolic reprogramming of cancer cell as a predictor of aggressive phenotype.
Saluja TS; Spadigam A; Dhupar A; Syed S
Tumour Biol; 2016 Apr; 37(4):5609-20. PubMed ID: 26577856
[TBL] [Abstract][Full Text] [Related]
2. Serum and salivary levels of lactate dehydrogenase in oral squamous cell carcinoma, oral lichen planus and oral lichenoid reaction.
Gholizadeh N; Alipanahi Ramandi M; Motiee-Langroudi M; Jafari M; Sharouny H; Sheykhbahaei N
BMC Oral Health; 2020 Nov; 20(1):314. PubMed ID: 33167957
[TBL] [Abstract][Full Text] [Related]
3. Serum and Saliva LDH Levels in Patients with Habit, Oral Potentially Malignant Disorders (OPMDs), and Oral Squamous Cell Carcinoma (OSCC): A Spectrophotometry Study.
Shah FY; Shetty DC; Kaur G; Gupta S; Pathak A; Aggarwal V
J Pharm Bioallied Sci; 2023 Jul; 15(Suppl 2):S881-S884. PubMed ID: 37694076
[TBL] [Abstract][Full Text] [Related]
4. Metabolic reprogramming of normal oral fibroblasts correlated with increased glycolytic metabolism of oral squamous cell carcinoma and precedes their activation into carcinoma associated fibroblasts.
Zhang Z; Gao Z; Rajthala S; Sapkota D; Dongre H; Parajuli H; Suliman S; Das R; Li L; Bindoff LA; Costea DE; Liang X
Cell Mol Life Sci; 2020 Mar; 77(6):1115-1133. PubMed ID: 31270582
[TBL] [Abstract][Full Text] [Related]
5. The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets.
Burns JE; Hurst CD; Knowles MA; Phillips RM; Allison SJ
Cancer Sci; 2021 Sep; 112(9):3822-3834. PubMed ID: 34181805
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Serum and Salivary Lactate Dehydrogenase Levels in Patients with Oral Potentially Malignant Conditions/Lesions: A Clinical and Biochemical Study.
Rao K; Babu SG; Shetty SR; Castelino RL
Indian J Community Med; 2024; 49(2):316-321. PubMed ID: 38665466
[TBL] [Abstract][Full Text] [Related]
7. Lactate Dehydrogenase as a Biomarker in Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis.
Mahapatra M; Panda A; Kumar H; Barman D; Talukdar R; Dakshinakabat P
Cureus; 2023 Dec; 15(12):e51008. PubMed ID: 38264399
[TBL] [Abstract][Full Text] [Related]
8. Lactate concentration in breast cancer using advanced magnetic resonance spectroscopy.
Cheung SM; Husain E; Masannat Y; Miller ID; Wahle K; Heys SD; He J
Br J Cancer; 2020 Jul; 123(2):261-267. PubMed ID: 32424149
[TBL] [Abstract][Full Text] [Related]
9. Relationship between transcriptional expression of pyruvate dehydrogenase and local control of disease in patients with oral cavity carcinomas.
León X; Bagué S; Holgado A; Quer M; Terra X; Camacho M; Avilés-Jurado FX
Acta Otorrinolaringol Esp (Engl Ed); 2023; 74(6):372-378. PubMed ID: 37730160
[TBL] [Abstract][Full Text] [Related]
10. The Ratio of Key Metabolic Transcripts Is a Predictive Biomarker of Breast Cancer Metastasis to the Lung.
Mathur D; Liao C; Lin W; La Ferlita A; Alaimo S; Taylor S; Zhong Y; Iacobuzio-Donahue C; Ferro A; Xavier JB
Cancer Res; 2023 Oct; 83(20):3478-3491. PubMed ID: 37526524
[TBL] [Abstract][Full Text] [Related]
11. On-chip dielectrophoretic recovery and detection of a lactate sensing probiotic from model human saliva.
Hamilton S; Shea D; Ibsen S; Brasino M
Electrophoresis; 2023 Feb; 44(3-4):442-449. PubMed ID: 36401837
[TBL] [Abstract][Full Text] [Related]
12. Genetic and Drug Inhibition of LDH-A: Effects on Murine Gliomas.
Maeda M; Ko M; Mane MM; Cohen IJ; Shindo M; Vemuri K; Serganova I; Blasberg R
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565435
[TBL] [Abstract][Full Text] [Related]
13. Targeting Lactate Dehydrogenase-B as a Strategy to Fight Cancer: Identification of Potential Inhibitors by In Silico Analysis and In Vitro Screening.
Vlasiou M; Nicolaidou V; Papaneophytou C
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896171
[TBL] [Abstract][Full Text] [Related]
14. Salivary markers for oral cancer detection.
Markopoulos AK; Michailidou EZ; Tzimagiorgis G
Open Dent J; 2010; 4():172-8. PubMed ID: 21673842
[TBL] [Abstract][Full Text] [Related]
15. Natural compounds as lactate dehydrogenase inhibitors: potential therapeutics for lactate dehydrogenase inhibitors-related diseases.
Han JH; Lee EJ; Park W; Ha KT; Chung HS
Front Pharmacol; 2023; 14():1275000. PubMed ID: 37915411
[TBL] [Abstract][Full Text] [Related]
16. Characterization of genetic and molecular tools for studying the endogenous expression of
Rai M; Carter SM; Shefali SA; Chawla G; Tennessen JM
bioRxiv; 2023 Jun; ():. PubMed ID: 37398276
[No Abstract] [Full Text] [Related]
17. On the Treatment of Cancer by the Lactate of Iron Taken by the Mouth and Injected into the Veins.
Brainard D
West J Med Surg; 1852 Aug; 10(2):153-156. PubMed ID: 38210679
[No Abstract] [Full Text] [Related]
18. Lactate dehydrogenase as a biomarker in oral cancer and oral submucous fibrosis.
Kallalli BN; Rawson K; Muzammil ; Singh A; Awati MA; Shivhare P
J Oral Pathol Med; 2016 Oct; 45(9):687-690. PubMed ID: 27132033
[TBL] [Abstract][Full Text] [Related]
19. Salivary Biomarkers for Oral Cancer Detection: An Exploratory Systematic Review.
Bastías D; Maturana A; Marín C; Martínez R; Niklander SE
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473882
[TBL] [Abstract][Full Text] [Related]
20. Identification of Metabolism-Associated Biomarkers for Early and Precise Diagnosis of Oral Squamous Cell Carcinoma.
Wang Y; Zhang X; Wang S; Li Z; Hu X; Yang X; Song Y; Jing Y; Hu Q; Ni Y
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
